Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate Coronary

Piotr Baruś1, Jaromir Hunia1, Rafał Kaczorowski1

  • 1First Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Insights

Mild-to-moderate chronic kidney disease (CKD) did not alter coronary plaque characteristics or lesion severity in intermediate coronary artery lesions. However, CKD patients faced higher risks of mortality and major adverse cardiovascular events over five years.

Area of Science:

  • Cardiology
  • Nephrology
  • Medical Imaging

Background:

  • Chronic coronary syndrome (CCS) progression is linked to chronic kidney disease (CKD).
  • Understanding the impact of renal function on coronary artery lesions is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate how mild-to-moderate renal dysfunction affects intermediate coronary artery lesions.
  • To assess the 5-year outcomes of patients with varying renal function.

Main Methods:

  • Prospective study of 100 patients with intermediate coronary stenosis.
  • Lesions evaluated using optical coherence tomography (OCT), fractional flow reserve (FFR), and intravascular ultrasound (IVUS).
  • Patients stratified into groups based on estimated glomerular filtration rate (eGFR).

Main Results:

  • No significant differences in plaque morphology or lesion severity between renal dysfunction groups.
  • Patients with mild-to-moderate renal dysfunction were older.
  • Elevated risk of all-cause mortality and major adverse cardiovascular events observed in patients with renal dysfunction over 5 years.

Conclusions:

  • Mild-to-moderate renal dysfunction does not significantly alter intermediate coronary stenosis characteristics (plaque morphology, FFR, IVUS).
  • Renal dysfunction is associated with increased long-term risk of mortality and major adverse cardiovascular events.
  • Further research is needed to explore the mechanisms linking CKD to adverse cardiovascular outcomes.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
90
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
367
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
85
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
791
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K